Inhibition of amyloid-β plaque formation by α-synuclein

被引：0
|
作者：
Teresa Bachhuber
Natalie Katzmarski
Joanna F McCarter
Desiree Loreth
Sabina Tahirovic
Frits Kamp
Claudia Abou-Ajram
Brigitte Nuscher
Alberto Serrano-Pozo
Alexandra Müller
Marco Prinz
Harald Steiner
Bradley T Hyman
Christian Haass
Melanie Meyer-Luehmann
机构：
[1] Adolf Butenandt Institute,Department of Biochemistry
[2] Ludwig-Maximilians University,Department of Neurology
[3] Neurocenter,Department of Metabolic Biochemistry
[4] University of Freiburg,undefined
[5] Faculty of Biology,undefined
[6] University of Freiburg,undefined
[7] German Center for Neurodegenerative Diseases (DZNE),undefined
[8] Ludwig-Maximilians University,undefined
[9] MassGeneral Institute for Neurodegenerative Disease,undefined
[10] Massachusetts General Hospital and Harvard Medical School,undefined
[11] Institute of Neuropathology,undefined
[12] University of Freiburg,undefined
[13] Centre for Biological Signalling Studies (BIOSS),undefined
[14] University of Freiburg,undefined
[15] Munich Cluster for Systems Neurology (SyNergy),undefined
来源：
Nature Medicine | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The introduction of α-synuclein into mouse models of Alzheimer's disease, either by intracerebral injection or transgenic overexpression, is found to inhibit the formation of hippocampal amyloid-β plaques.
引用
收藏
页码：802 / 807
页数：5
相关论文
共 50 条
  • [41] Mechanistic insights into the inhibition of amyloid-β aggregation by chitosan
    Gotla, Suhas
    Matysiak, Silvina
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2023, 25 (14) : 10113 - 10120
  • [42] Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
    David J. Irwin
    Virginia M.-Y. Lee
    John Q. Trojanowski
    Nature Reviews Neuroscience, 2013, 14 : 626 - 636
  • [43] Polyfluorinated bis-styrylbenzenes as amyloid-β plaque binding ligands
    Nabuurs, Rob J. A.
    Kapoerchan, Varsha V.
    Metaxas, Athanasios
    de Jongh, Sanne
    de Backer, Maaike
    Welling, Mick M.
    Jiskoot, Wim
    Windhorst, Albert D.
    Overkleeft, Hermen S.
    van Buchem, Mark A.
    Overhand, Mark
    van der Weerd, Louise
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (08) : 2469 - 2481
  • [44] Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders
    Valera, Elvira
    Spencer, Brian
    Masliah, Eliezer
    NEUROTHERAPEUTICS, 2016, 13 (01) : 179 - 189
  • [45] Amyloid-β oligomers:: their production, toxicity and therapeutic inhibition
    Walsh, DM
    Klyubin, I
    Fadeeva, JV
    Rowan, MJ
    Selkoe, DJ
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 : 552 - 557
  • [46] Using mass spectrometry-based methods to understand amyloid formation and inhibition of alpha-synuclein and amyloid beta
    Wagner, Wesley J.
    Gross, Michael L.
    MASS SPECTROMETRY REVIEWS, 2024, 43 (04) : 782 - 825
  • [47] α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation
    Falke, Marcel
    Victor, Julian
    Woerdehoff, Michael M.
    Peduzzo, Alessia
    Zhang, Tao
    Schroeder, Gunnar F.
    Buell, Alexander K.
    Hoyer, Wolfgang
    Etzkorn, Manuel
    CHEMISTRY AND PHYSICS OF LIPIDS, 2019, 220 : 57 - 65
  • [48] Oxidized glutathione stimulated the amyloid formation of α-synuclein
    Paik, SR
    Lee, DY
    Cho, HJ
    Lee, EN
    Chang, CS
    FEBS LETTERS, 2003, 537 (1-3) : 63 - 67
  • [49] Membrane Remodeling by α-Synuclein and Effects on Amyloid Formation
    Jiang, Zhiping
    de Messieres, Michel
    Lee, Jennifer C.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2013, 135 (43) : 15970 - 15973
  • [50] The hot sites of α-synuclein in amyloid fibril formation
    Khammari, Anahita
    Arab, Seyed Shahriar
    Ejtehadi, Mohammad Reza
    SCIENTIFIC REPORTS, 2020, 10 (01)
12345